Literature DB >> 17690979

A single nucleotide substitution (-107C-->G) in the hMLH1 promoter found in colorectal cancer population reduces transcriptional activity.

Xiaoling Zhong1, Michitsune Arita, Kanae Yamada, Hisahiko Sugiyama, Ke Tan, Shinsaku Kanazawa, Junichi Koike, Tatsuo Teramoto, Hiromichi Hemmi.   

Abstract

Inactivation of the DNA mismatch repair gene hMLH1 predisposes one to colorectal cancer. We have identified a C to G nucleotide substitution at position -107 relative to the hMLH1 gene translation initiation site in three of 163 colorectal cancer patients with an allele frequency of 0.0092 (3/326). One of the three -107G alleles occurred in one patient out of five with reduced hMLH1 expression in the tumor tissue. The -107G was not found in 63 healthy individuals. This substitution reduced transcriptional activity by 51% compared with -107C (P<0.01) and impeded the promoter-binding capacity of nuclear proteins. Although the small number of identified -107G alleles is insufficient to evaluate the contribution to the carcinogenesis and clinicopathological properties of the tumors, the effects of -107G on hMLH1 gene transcription and nuclear protein binding to the promoter sequence implicate the site, including -107C, as a crucial element interacting with the activator that maintains hMLH1 gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690979     DOI: 10.1007/s10528-007-9104-z

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  1 in total

1.  MLH1-rheMac hereditary nonpolyposis colorectal cancer syndrome in rhesus macaques.

Authors:  David W Brammer; Patrick J Gillespie; Mei Tian; Daniel Young; Muthuswamy Raveendran; Lawrence E Williams; Mihai Gagea; Fernando J Benavides; Carlos J Perez; Russell R Broaddus; Bruce J Bernacky; Kirstin F Barnhart; Mian M Alauddin; Manoop S Bhutani; Richard A Gibbs; Richard L Sidman; Renata Pasqualini; Wadih Arap; Jeffrey Rogers; Christian R Abee; Juri G Gelovani
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-28       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.